Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

Figure][1] Jason S. Lewis, PhD Professor Jason S. Lewis holds the Emily Tow Chair at Memorial Sloan Kettering (MSK) in New York. He serves as deputy director of the Sloan Kettering Institute, ...

Incidental findings from PET are common, induce unnecessary patient anxiety, and incur substantial costs to the health care system, with further diagnostic clarification potentially delaying important ...

The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...

Radiopharmaceuticals represent a promising new frontier in cancer therapy. In the United States, cancer is the second leading cause of death. There is an urgent need to develop new therapies to meet ...

The recently released Biograph mMR is the first commercially available integrated whole-body PET/MR scanner. There are considerable advantages to integrating both modalities in a single scanner that ...

On the basis of the qualitative 5-point scale, the studies were grouped as positive or negative for primary tumor, right neck, left neck, and overall assessment. Scores 1, 2, and 3, which represent ...

Journal of Nuclear Medicine March 2026, jnumed.125.271031; DOI: https://doi.org/10.2967/jnumed.125.271031 ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 251856; ...

Journal of Nuclear Medicine January 2025, jnumed.124.269268; DOI: https://doi.org/10.2967/jnumed.124.269268 The only research study on humans (3), using a tumor ...

Journal of Nuclear Medicine March 2026, jnumed.125.271296; DOI: https://doi.org/10.2967/jnumed.125.271296 ...

A landmark study from the Institute of Medicine reported that the assessment of cognitive difficulties in children with epilepsy is timely and imperative. Anticonvulsant-induced cognitive impairment ...